Premium
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers
Author(s) -
Strafella Antonio P.,
Bohnen Nicolaas I.,
Perlmutter Joel S.,
Eidelberg David,
Pavese Nicola,
Eimeren Thilo,
Piccini Paola,
Politis Marios,
Thobois Stephane,
Ceravolo Roberto,
Higuchi Makoto,
Kaasinen Valtteri,
Masellis Mario,
Peralta M. Cecilia,
Obeso Ignacio,
PinedaPardo Jose Ángel,
Cilia Roberto,
Ballanger Benedicte,
Niethammer Martin,
Stoessl Jon A.
Publication year - 2017
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.26907
Subject(s) - parkinson's disease , molecular imaging , neuroscience , medicine , movement disorders , neuroimaging , disease , pathology , psychology , in vivo , biology , microbiology and biotechnology
Molecular imaging has proven to be a powerful tool for investigation of parkinsonian disorders. One current challenge is to identify biomarkers of early changes that may predict the clinical trajectory of parkinsonian disorders. Exciting new tracer developments hold the potential for in vivo markers of underlying pathology. Herein, we provide an overview of molecular imaging advances and how these approaches help us to understand PD and atypical parkinsonisms. © 2016 International Parkinson and Movement Disorder Society.